Psychobiological aspects of atopic dermatitis: An overview

Psychotherapy and Psychosomatics

Volumn 70, Issue 1, 2001, Pages 6-16

  Buske Kirschbaum, Angelika ^a   Geiben, Andrea ^a   Hellhammer, Dirk ^a  

^a UNIVERSITY OF TRIER   (Germany)

Author keywords

Atopic dermatitis; Hypothalamus pituitary adrenal axis; Psychoneuroimmunology; Stress; Sympathetic nervous system

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOTOXIN;

ARTICLE; ATOPIC DERMATITIS; DISEASE ASSOCIATION; DISEASE COURSE; EMOTIONAL STRESS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; PREVALENCE; PSYCHOBIOLOGY;

DEPRESSIVE DISORDER; DERMATITIS, ATOPIC; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PERSONALITY; PITUITARY-ADRENAL SYSTEM; PSYCHONEUROIMMUNOLOGY; STRESS, PSYCHOLOGICAL;

EID: 0035171216     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056219     Document Type: Article

References (84)

1. Pathogenesis of atopic dermatitis
2. Atopic dermatitis: An update
3. New concepts in atopic dermatitis
4. Atopic dermatitis: Triggering factors
5. Psychological profile of the atopic patient
6. Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic disease
7. Atopic dermatitis - The skin manifestation of atopy
8. Allergic and immunologic skin disorders
9. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis
10. Psychoneuroimmunology
11. Stress and immune fnctions in humans
12. Psychologic characteristics associated with acute stressor-induced leukocyte subset redistribution
13. Atopic allergy and other hypersensitivities
14. IgE receptors on Langerhans cells: Their significance in the pathology of atopic eczema
15. An update on human Th1 and Th2 cells
16. Th1 and Th2 in human diseases
17. Infants with atopic dermatitis: Maternal hopelessness, child-rearing attitudes and perceived infant temperament
18. Psychosomatische aspekte der eltern-kind-beziehung bei atopischem ekzem im kindesalter. II. Erziehungsstil, familiensituation im zeichentest und strukturiertem interview
19. Psychosocial adjustment in preschool children with atopic eczema
20. Neurotic symptoms and emotional factors in atopic dermatitis
21. Atopic dermatitis: A clinical psychiatric study
22. Psychological factors in skin disorders
23. Das krankheitskonzept bei patienten mit atopischer dermatitis
24. Psychosomatic concepts in atopic dermatitis - A critique
25. Psychosocial correlates of estrogen and progesteron receptors in breast cancer patients
26. Rheumatoid arthritis: Review of psychological factors related to etiology, effects, and treatment
27. Depression modulates pruritus perception: A study of pruritus in psoriasis, atopic dermatitis, and chronic idiophathic urticaria
28. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia
29. Atopic dermatitis, anxiety and conditioned scratch responses
30. Personality characteristics and serum IgE levels in patients with atopic dermatitis
31. Stress as a precipitant factor of eczema
32. Prognosis of atopic dermatitis. A prospective study in early adulthood
33. The relationship of stress and family environment to atopic dermatitis symptoms in children
34. Atopic dermatitis and stress: Possible role of negative communication with significant others
35. Experimental basis for neural-immune interactions
36. Modulation of immune cell function by the autonomic nervous system
37. Glucocorticoids and immune function
38. The hypothalamus-pituitary-adrenal axis and immune mediated inflammation
39. Sind verschiebungen des zirkadianen cortisolrhythmus ein endokrines symptom des endogenen ekzems?
40. Attenuated free cortisol response to psychosocial stress in children with atopic dermatitis
41. Cortisol, corticotropin, and β-endorphin responses to corticotropin-releasing hormone in patients with atopic eczema
42. Elevated glucocorticoid receptor concentration before and after glucocortioid therapy in peripheral mononuclear leukocytes of patients with atopic dermatitis
43. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats
44. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids
45. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: Toxicity, immunological and hormonal aspects
46. Steroid regulation of cytokines. Relevance for TH1-to-TH2 shift?
47. Glucocorticoids promote a TH2 cytokine response by CD4+ cells in vitro
48. Alterations in interleukin-4 and antibody production following pheromone exposure: Role of glucocorticoids
49. Glucocorticoids: Mechanisms of action and anti-inflammatory potential in asthma
50. Molecular mechanisms of anti-inflammatory action of glucocorticoids
51. Noradrenergic and peptidergic innervation of lymphoid organs
52. Mast cell invasion of peripheral nerve in skin lesions of atopic dermatitis
53. Increased number of immunoreactive nerve fibers in atopic dermatitis
54. The beta adrenergic theory of the atopic abnormality in bronchial asthma
55. Role of cyclic nucleotide metabolism in the pathophysiology of atopic eczema
56. 2 histamine granulocyte release in active atopic eczema
57. Elevated leukocyte cyclic AMP-phophodiesterase in atopic disease: A possible mechanism for cyclic AMP-agonist hyporesponsiveness
58. Elevated cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from children with atopic dermatitis
59. Increased interleukin-4 production by atopic mononuclear leukoytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition
60. Sex hormones and immune function
61. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis
62. Growth hormone in immunobiology
63. Pruritic skin disease, psychological stress and the itch sensation
64. Experimental histamine pruritus: Influence of physical and physiological factors on threshold reactivity
65. Cytokines in atopic dermatitis
66. Depression and immunocompetence: A review of the literature
67. Motivational syndromes associated with natural killer cell activity
68. The relationship between repressive and defensive coping styles and monocyte, eosinophile, and serum glucose levels: Support for the opioid peptide hypothesis of repression
69. Genes, environment and personality
70. The role of noradrenergic function in human anxiety and depression
71. Central mediation of the effects of interleukin-1 on social exploration and body weight in mice
72. Central interleukin-1 receptors as mediators of sickness
73. Behavioral consequences of virus infection
74. Behavioral effects of cytokines: An insight into mechanisms of sickness behavior
75. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism. Comparison with interleukin-1
76. Local administration of recombinant human interleukin-1b in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity and body temperature
77. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
78. Modulation of hippocampal acetylcholine release: A potent central action of interleukin-2
79. Cytokines for psychologists: Implications of bidirectional immune to brain-communication for understanding behavior, mood, and cognition
80. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells
81. Effects of interleukin-2 and alpha-interferon cytokine immunotherapy on the mood and cognitive performance of cancer patients